The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

Nicainoprol     [8-[2-hydroxy-3-(propan-2- ylamino)propoxy]...

Synonyms: Nicainoprolum, CAS-924, CHEMBL2106788, SureCN1816282, AC1L2FMP, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Nicainoprol

 

High impact information on Nicainoprol

 

Anatomical context of Nicainoprol

 

Analytical, diagnostic and therapeutic context of Nicainoprol

References

  1. Electrophysiological effects of intravenous nicaïnoprol, a new antiarrhythmic agent, in 11 patients. Libersa, C.C., Caron, J.F., Kacet, S., Dagano, J., Vincent, A., Dupuis, B., Gayet, J.L., Lekieffre, J.P. Eur. Heart J. (1988) [Pubmed]
  2. Effects of nicainoprol on reperfusion arrhythmia in the isolated working rat heart and on ischemia and reperfusion arrhythmia and myocardial infarct size in the anesthetized rat. Martorana, P.A., Linz, W., Göbel, H., Petry, P., Schölkens, B.A. Eur. J. Pharmacol. (1987) [Pubmed]
  3. Disposition kinetics and dynamics of nicainoprol, a new antiarrhythmic agent, in humans. Ishizaki, T., Horai, Y., Kubota, K., Minegishi, A., Echizen, H., Chiba, K. Clin. Pharmacol. Ther. (1987) [Pubmed]
  4. Modification by hypoxia, hyperkalaemia and acidosis of the cardiac electrophysiological effects of a range of antiarrhythmic drugs. Pacini, D.J., Boachie-Ansah, G., Kane, K.A. Br. J. Pharmacol. (1992) [Pubmed]
  5. Modelling frequency- and voltage-dependent effects of a class I antiarrhythmic drug (nicainoprol) on Vmax of the cardiac action potential from guinea-pig papillary muscle. Weirich, J., Antoni, H. Naunyn Schmiedebergs Arch. Pharmacol. (1989) [Pubmed]
  6. Antiarrhythmic effect of a new class 1 antiarrhythmic drug, nicainoprol, on canine ventricular arrhythmias. Hashimoto, K., Akiyama, K., Mitsuhashi, H. Jpn. J. Pharmacol. (1989) [Pubmed]
  7. Dose-related antiarrhythmic effects of nicainoprol in patients with chronic ventricular arrhythmias--a double-blind, placebo-controlled, cross-over multicentre trial. Nicainoprol Study Group. Schneider, W., Reifart, N., Blaeser, A., Ostrowski, J., Kaltenbach, M., Kober, G. Eur. Heart J. (1991) [Pubmed]
  8. Determination of nicainoprol, a new antiarrhythmic agent, in human plasma and urine by high-performance liquid chromatography. Horai, Y., Ishizaki, T. J. Chromatogr. (1986) [Pubmed]
 
WikiGenes - Universities